Business Data Enrichment Services
ID: FDA-RFI-75F40125Q00020Type: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFFOOD AND DRUG ADMINISTRATIONFDA OFFICE OF ACQ GRANT SVCSBeltsville, MD, 20705, USA

NAICS

Other Computer Related Services (541519)

PSC

SUPPORT- PROFESSIONAL: OTHER (R499)

Original Source

https://sam.gov/opp/d3ea3920caf14d47b3c7e2432ad875d6/view
Timeline
    Description

    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking information on Business Data Enrichment Services to support the establishment of an enterprise master data management program. The primary objective is to enhance the accuracy and completeness of business data across operational and analytical systems, which is crucial for regulatory compliance and public health initiatives. This Request for Information (RFI) is part of the FDA's efforts to gather insights from the marketplace regarding potential solutions and capabilities, particularly in light of legislative requirements such as the Drug Supply Chain and Security Act. Interested stakeholders must submit their responses by November 15, 2024, and can direct inquiries to Noah Padilla at Noah.Padilla@fda.hhs.gov or Peter Lee at peter.lee@fda.hhs.gov.

    Point(s) of Contact
    Noah Padilla
    Noah.Padilla@fda.hhs.gov
    Peter Lee
    peter.lee@fda.hhs.gov
    Files
    Title
    Posted
    Appendix A - Enterprise Performance Life Cycle Framework.pdf
    The Enterprise Performance Life Cycle (EPLC) Framework, established by the U.S. Department of Health and Human Services (HHS), provides a comprehensive methodology for managing IT projects. It consists of ten distinct phases aimed at ensuring IT investments align with business objectives and comply with federal standards. These phases include Initiation, Concept, Planning, Requirements Analysis, Design, Development, Testing, Implementation, Operations and Maintenance, and Disposition. The framework emphasizes structured project planning, risk assessment, and stakeholder engagement throughout the project life cycle. Each phase has defined activities, responsibilities, exit criteria, and mandated Stage Gate Reviews to maintain quality and technical feasibility, allowing for tailored approaches based on project complexity and urgency. By adopting the EPLC framework, HHS seeks to enhance project management efficiency, minimize risks associated with IT investments, and improve alignment with strategic health goals. The collaborative effort of stakeholders, including Business Owners and Critical Partners, is crucial to achieving successful project outcomes. Overall, the EPLC framework serves as a vital tool for managing HHS's extensive IT portfolio in a transparent and accountable manner.
    Attachment A - RFI Questionnaire.xlsx
    The document outlines a solicitation for a series of data enrichment and analytical services across multiple tiers and task areas for government contracts. It includes organizational information requirements, such as unique identification numbers and website addresses, as well as contact details of representatives. The primary objectives encompass Tiered services related to operational data enrichment, analytics, social media, national brand sales data, and supply chain-related data, each requiring expressions of interest for contracting as a Prime Contractor or Subcontractor. Each tier necessitates justification for qualifications, evaluation preferences, and details about service scope including foreign and domestic information. Supporting task areas include program and project administration, document management, data matching and validation, IT consulting, and technical support. Feedback requests elaborate on recommended contract types, evaluation criteria, and considerations for effective integration of third-party data products. Overall, the document serves as a Request for Proposals (RFP) highlighting operational needs for data services within federal and possibly state and local frameworks, seeking capable organizations to enhance analytical and operational capabilities through detailed evaluations and competitive responses. The scope aims to ensure comprehensive service delivery aligned with government standards.
    Attachment B - SOW_102424.docx
    The FDA is seeking business data enrichment services through an Indefinite Delivery/Indefinite Quantity (IDIQ) contract to enhance its data management capabilities for regulated entities. The primary objectives include improving the accuracy and completeness of business entity data, ensuring proper identification and verification throughout all interactions with the FDA, and leveraging third-party data services for enriched insights. The contract outlines key areas of focus, including operational data enrichment, analytics, social media data insights, and national sales data access. The contractor will provide validation and verification services for business entities, track real-time operational statuses, and support comprehensive investigations related to regulatory compliance. Additionally, the FDA aims to establish effective risk assessment methodologies and enhance interoperability between diverse data sources. The document details various task areas, including matching and validation of records, system and data hosting, customized interfaces, and technical support aimed at improving data quality and providing robust analytics. Ultimately, this initiative demonstrates the FDA's commitment to optimizing its IT systems and information management processes to support public health outcomes effectively through enhanced regulatory oversight and business intelligence.
    FDA-RFI-75F40125Q00020 Business Data Enrichment Services.docx
    The FDA has issued a Request for Information (RFI) to gather input on Business Data Enrichment Services, essential for establishing an enterprise master data management program aimed at enhancing the accuracy and completeness of business data across various operational and analytical systems. This initiative supports the agency's mission to secure public health and ensure data integrity, particularly in light of legislation like the Drug Supply Chain and Security Act and Executive Orders focused on public health supply chains. The FDA seeks stakeholders to provide responses specifically in Attachment A of the RFI. They emphasize the importance of coherent, precise contributions that demonstrate capabilities rather than basic assertions. The RFI explicitly states that it is not a request for quotes and that no contract will be awarded at this time. The agency will not cover expenses incurred by respondents, and any information submitted will become government property. Respondents must submit their responses by November 15, 2024, as the FDA plans to use the gathered insights to assess the feasibility of pursuing the necessary business data solutions, geared towards fostering an integrated and efficient data management framework in accordance with existing regulations and the agency’s IT Strategy Plan for 2024-2027.
    Lifecycle
    Title
    Type
    Business Data Enrichment Services
    Currently viewing
    Sources Sought
    Similar Opportunities
    Request for Information: Literature Search and Summarization Tools
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking information on literature search and summarization tools to enhance drug safety research. The FDA aims to identify commercial tools that utilize artificial intelligence, particularly natural language processing (NLP), to assist in the classification, summarization, and extraction of relevant medical literature, addressing challenges in evaluating adverse drug reactions. This Request for Information (RFI) is part of a market research initiative and does not constitute a solicitation for contracts; interested parties are encouraged to submit their responses by the specified deadline to Ian Weiss at ian.weiss@fda.hhs.gov, with a focus on the tool's capabilities, interoperability, and validation methods.
    PRIMO Software Licensing
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking qualified small businesses to provide PRIMO Software Licensing and Maintenance Support Services. The procurement involves supplying 21 PRIMO software licenses for a base year, with two additional option years, to ensure the continuous operation of the FDA's CFSAN CAEMS system. This software is crucial for pharmacovigilance and regulatory compliance, enhancing the FDA's capabilities in monitoring food safety. Interested parties must submit their quotes by August 26, 2024, and are encouraged to contact Roosevelt Walker at roosevelt.walker@fda.hhs.gov for further details. The contract will be awarded as a firm-fixed-price purchase order, emphasizing compliance with federal acquisition regulations and accessibility standards.
    FY24 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science Award Notice
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Food and Drug Administration (FDA), has announced the FY24 Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science. This opportunity aims to support innovative research projects that enhance regulatory science, with a focus on health, medical, and biotechnology advancements. The awarded contracts, totaling over $24 million, cover a range of critical topics including drug safety, gene therapy, and methodologies for assessing pediatric opioid exposure, reflecting the federal government's commitment to fostering research initiatives that improve healthcare delivery and regulatory processes. Interested parties can contact Ian Weiss at Ian.Weiss@fda.hhs.gov or by phone at 301-796-5728 for further information.
    FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Food and Drug Administration (FDA), is soliciting proposals for the FY25 Broad Agency Announcement (BAA) aimed at advancing research and development in regulatory science. This initiative seeks to acquire innovative research proposals that enhance the FDA's mission to protect public health by modernizing the evaluation of FDA-regulated products and improving post-market surveillance. Eligible applicants, including private organizations and academic institutions, are encouraged to submit proposals that address critical knowledge gaps and align with FDA priorities, with a submission deadline for full proposals set for February 24, 2025. Interested parties can contact Ian Weiss at Ian.Weiss@fda.hhs.gov or by phone at 301-796-5728 for further information.
    Register now for the Fiscal Year 2025 FDA Small Business Fair
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is hosting the Fiscal Year 2025 FDA Small Business Fair on November 14, 2024, at the FDA White Oak Campus in Silver Spring, Maryland. This event aims to foster partnerships between small and large businesses, providing small business representatives the opportunity to engage in one-on-one matchmaking meetings with FDA officials to discuss upcoming contract requirements and potential subcontracting opportunities. The fair is a crucial platform for small businesses to navigate the federal procurement landscape, with a total federal obligation exceeding $1.5 billion in FY 2024 across various sectors, including custom computer programming and biotechnology research. Registration is mandatory and closes on November 1, 2024, at 5:00 PM ET; for inquiries, attendees can contact the Small Business Outreach team at FDA-SmallBusinessOutreach@fda.hhs.gov.
    Decentralized Clinical Operations for Healthcare and Research (D-COHRe) Partnership Solicitation
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services (HHS) is seeking proposals for the Decentralized Clinical Operations for Healthcare and Research (D-COHRe) Partnership Solicitation, aimed at enhancing decentralized healthcare services and clinical trial capabilities. This initiative invites partnerships with organizations such as retail pharmacies, telemedicine providers, and Clinical Research Organizations (CROs) to develop sustainable infrastructures for conducting decentralized clinical trials, particularly in response to public health emergencies. The program emphasizes the importance of innovative approaches to medical countermeasure development and aims to address challenges in decentralized trial implementation while ensuring diverse participant representation. Interested parties must submit their proposals by December 9, 2024, at 12:00 PM EST, with an anticipated funding amount of up to $100 million distributed over a five-year performance period. For inquiries, contact William K. Hunter at LaunchOfficeContracting@hhs.gov.
    DA10--**REQUEST FOR INFORMATION** Pharmacy Web-Based Compounding Documentation System VISN 10 Pharmacy Operations
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the VISN 10 Pharmacy Operations, is seeking information regarding a comprehensive web-based compounding documentation system through a Request for Information (RFI). The objective is to identify potential suppliers capable of providing a system that meets regulatory standards for compounded sterile preparations (CSP) and supports documentation, training, and reporting requirements essential for patient safety and risk mitigation. This system is crucial for ensuring compliance with guidelines set forth by the United States Pharmacopeia (USP) and other regulatory bodies, while also addressing the potential for human error in compounding processes. Interested vendors are encouraged to submit their responses by 1:30 PM EST on October 31, 2024, to Teri Miller at Teri.Miller@VA.gov and Josh Kovar at Joshua.Kovar@VA.gov, ensuring to include their business size and socio-economic categories in their capabilities statement.
    Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH) through the National Center for Advancing Translational Sciences (NCATS), is seeking qualified small businesses to provide Chemistry, Manufacturing, and Controls (CMC) and related services for the development of drug products. The objective of this procurement is to support the Therapeutic Development Branch in ensuring the delivery of drug products of sufficient quality and quantity for preclinical, IND-enabling, and clinical studies, which are critical for advancing therapeutic candidates through the drug development pipeline. This opportunity is part of a Small Business Sources Sought notice, aimed at gathering information on the capabilities of small businesses to fulfill these requirements, with a focus on compliance with applicable regulations and the potential for a multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract. Interested vendors must submit their capability statements by 10:00 AM Eastern Time on July 21, 2024, to Michelle Cecilia at michelle.cecilia@nih.gov.
    Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting proposals for Chemistry, Manufacturing, and Controls (CMC) services related to the development of drug substances, as outlined in RFP Number 75N95024R00094. The primary objective is to ensure the provision of high-quality drug substances to support preclinical and Investigational New Drug (IND)-enabling studies, which are critical for advancing therapeutic innovations. This opportunity emphasizes compliance with current Good Manufacturing Practices (cGMP) and requires detailed reporting and documentation throughout the contract period. Interested contractors should note that the proposal submission deadline is December 3, 2024, with a maximum funding amount of $49.7 million anticipated for the contract period from September 1, 2025, to May 14, 2031. For further inquiries, potential bidders can contact Samson Shifaraw at samson.shifaraw@nih.gov or Valerie Whipple at valerie.whipple@nih.gov.
    DocuWare License and Annual Maintenance and Software Support Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a firm-fixed price contract for DocuWare License and Annual Maintenance and Software Support Services. This procurement aims to provide ongoing support for the DocuWare software system, which is critical for managing over 80,000 active medical and donor records within the Department of Transfusion Medicine, ensuring compliance with federal regulations. The NIH has determined that only DocuWare Corporation can fulfill this requirement without incurring significant costs associated with transitioning to a new vendor, including retraining and system redevelopment. Interested parties may express their interest and capabilities to Tasha Lowe at lowet2@mail.nih.gov by November 4, 2024, at 12 PM.